NCT00410904View on ClinicalTrials.gov

AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

July 31, 2013

Study Completion Date

March 31, 2014

Conditions
Recurrent Non-small Cell Lung Cancer
Interventions
DRUG

cediranib maleate

DRUG

pemetrexed disodium

Trial Locations (2)

21201

University of Maryland/Greenebaum Cancer Center, Baltimore

48201

Wayne State University/Karmanos Cancer Institute, Detroit

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00410904 - AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter